多肽产品目录6
- 属性
- 详情
- 产地： 加拿大
- 关注度： 次
- 品牌： PLlabs
- 型号： P******
- 厂商性质： 生产型,服务型,
- 价格： 电议
- 添加时间： 2014/6/6
产品介绍
| P2001360 | GIP (3 - 42), human | Glu-Gly-Thr-Phe-Ile-Ser-Asp- Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile- His-Gln-Gln-Asp-Phe-Val-Asn- Trp-Leu-Leu-Ala-Gln-Lys-Gly- Lys-Lys-Asn-Asp-Trp-Lys-His- Asn-Ile-Thr-Gln |
| P2001361 | GIP, mouse, rat | Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser- Asp-Tyr-Ser-Ile-Ala-Met-Asp- Lys-Ile-Arg-Gln-Gln-Asp-Phe- Val-Asn-Trp-Leu-Leu-Ala-Gln- Lys-Gly-Lys-Lys-Asn-Asp-Trp- Lys-His-Asn-Ile-Thr-Gln |
| P2001362 | GIP, porcine | Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser- Asp-Tyr-Ser-Ile-Ala-Met-Asp- Lys-Ile-Arg-Gln-Gln-Asp-Phe- Val-Asn-Trp-Leu-Leu-Ala-Gln- Lys-Gly-Lys-Lys-Ser-Asp-Trp- Lys-His-Asn-Ile-Thr-Gln |
| P2001364 | GLP-1 (1-37) (human, bovine, guinea pig, mouse, rat) | His-Asp-Glu-Phe-Glu-Arg-His- Ala-Glu-Gly-Thr-Phe-Thr-Ser- Asp-Val-Ser-Ser-Tyr-Leu-Glu- Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile- Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly |
| P2001365 | GLP-1 (7-36) amide (chicken, common turkey) | His-Ala-Glu-Gly-Thr-Tyr-Thr-Ser- Asp-Ile-Thr-Ser-Tyr-Leu-Glu-Gly- Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala- Trp-Leu-Val-Asn-Gly-Arg-NH2 |
| P2001366 | GLP-1 (7-36)-Lys(biotinyl) amide (human, bovine, guinea pig, mouse, rat) | His-Ala-Glu-Gly-Thr-Phe-Thr- Ser-Asp-Val-Ser-Ser-Tyr-Leu- Glu-Gly-Gln-Ala-Ala-Lys-Glu- Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly- Arg-Lys(bio) -NH2 |
| P2001367 | GLP-1 (9-36) amide (human, bovine, guinea pig, mouse, porcine, rat) | Glu-Gly-Thr-Phe-Thr-Ser-Asp- Val-Ser-Ser-Tyr-Leu-Glu-Gly- Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala- Trp-Leu-Val-Lys-Gly-Arg-NH2 |
| P2001368 | GLP-2 (1-33) (human) | His-Ala-Asp-Gly-Ser-Phe-Ser- Asp-Glu-Met-Asn-Thr-Ile- Leu-Asp-Asn-Leu-Ala-Ala-Arg- Asp-Phe-Ile-Asn-Trp-Leu-Ile- Gln-Thr-Lys-Ile-Thr-Asp |
| P2001369 | GLP-2 (1-34) (human) | His-Ala-Asp-Gly-Ser-Phe-Ser- Asp-Glu-Met-Asn-Thr-Ile- Leu-Asp-Asn-Leu-Ala-Ala-Arg- Asp-Phe-Ile-Asn-Trp-Leu-Ile- Gln-Thr-Lys-Ile-Thr-Asp-Arg |
| P2001370 | GLP-2 (rat) | His-Ala-Asp-Gly-Ser-Phe-Ser- Asp-Glu-Met-Asn-Thr-Ile- Leu-Asp-Asn-Leu-Ala-Thr-Arg- Asp-Phe-Ile-Asn-Trp-Leu-Ile- Gln-Thr-Lys-Ile-Thr-Asp |
| P2001372 | Glucagon - Like Peptide 1, (GLP - 1) amide, human | His-Asp-Glu-Phe-Glu-Arg-His- Ala-Glu-Gly-Thr-Phe-Thr-Ser- Asp-Val-Ser-Ser-Tyr-Leu-Glu- Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile- Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 |
| P2001373 | Glucagon (1 - 37), porcine; Oxyntomodulin, porcine | His-Ser-Gln-Gly-Thr-Phe-Thr- Ser-Asp-Tyr-Ser-Lys-Tyr-Leu- Asp-Ser-Arg-Arg-Ala-Gln-Asp- Phe-Val-Gln-Trp-Leu-Met-Asn- Thr-Lys-Arg-Asn-Lys-Asn-Asn- Ile-Ala |
| P2001402 | GRF (free acid) (human) | Tyr-Ala-Asp-Ala-Ile-Phe-Thr- Asn-Ser-Tyr-Arg-Lys-Val-Leu- Gly-Gln-Leu-Ser-Ala-Arg-Lys- Leu-Leu-Gln-Asp-Ile-Met-Ser- Arg-Gln-Gln-Gly-Glu-Ser-Asn- Gln-Glu-Arg-Gly-Ala-Arg-Ala- Arg-Leu |
| P2001403 | GRF, porcine | Tyr-Ala-Asp-Ala-Ile-Phe-Thr- Asn-Ser-Tyr-Arg-Lys-Val-Leu- Gly-Gln-Leu-Ser-Ala-Arg-Lys- Leu-Leu-Gln-Asp-Ile-Met-Ser- Arg-Gln-Gln-Gly-Glu-Arg-Asn- Gln-Glu-Gln-Gly-Ala-Arg-Val- Arg-Leu-NH2 |
| P2001409 | Growth Hormone Releasing Factor, GRF (1 - 40), amide, human | Tyr-Ala-Asp-Ala-Ile-Phe-Thr- Asn-Ser-Tyr-Arg-Lys-Val-Leu- Gly-Gln-Leu-Ser-Ala-Arg-Lys- Leu-Leu-Gln-Asp-Ile-Met-Ser- Arg-Gln-Gln-Gly-Glu-Ser-Asn- Gln-Glu-Arg-Gly-Ala-NH2 |
| P2001410 | Growth Hormone Releasing Factor, GRF (1 - 44), amide, bovine | Tyr-Ala-Asp-Ala-Ile-Phe-Thr- Asn-Ser-Tyr-Arg-Lys-Val-Leu- Gly-Gln-Leu-Ser-Ala-Arg-Lys- Leu-Leu-Gln-Asp-Ile-Met-Asn- Arg-Gln-Gln-Gly-Glu-Arg-Asn- Gln-Glu-Gln-Gly-Ala-Lys-Val- Arg-Leu-NH2 |
| P2001411 | Growth Hormone Releasing Factor, GRF, (1 - 40), human | Tyr-Ala-Asp-Ala-Ile-Phe-Thr- Asn-Ser-Tyr-Arg-Lys-Val-Leu- Gly-Gln-Leu-Ser-Ala-Arg-Lys- Leu-Leu-Gln-Asp-Ile-Met-Ser- Arg-Gln-Gln-Gly-Glu-Ser-Asn- Gln-Glu-Arg-Gly-Ala |
| P2001414 | GRPP (human) | Arg-Ser-Leu-Gln-Asp-Thr-Glu- Glu-Lys-Ser-Arg-Ser-Phe-Ser- Ala-Ser-Gln-Ala-Asp-Pro-Leu- Ser-Asp-Pro-Asp-Gln-Met-Asn- Glu-Asp |
| P2001447 | Histatin 3 (H3) | Asp-Ser-His-Ala-Lys-Arg-His- His-Gly-Tyr-Lys-Arg-Lys-Phe- His-Glu-Lys-His-His-Ser-His-Arg- Gly-Tyr-Arg-Ser-Asn-Tyr-Leu- Tyr-Asp-Asn |
| P2001473 | HIV-gp41-Antigenic Peptide 5 | Arg-Val-Thr-Ala-Ile-Glu-Lys-Tyr- Leu-Gln-Asp-Gln-Ala-Arg-Leu- Asn-Ser-Trp-Gly-Cys-Ala-Phe- Arg-Gln-Val-Cys-His-Thr-Thr- Val-Pro-Trp-Val-Asn-Asp-Ser- NH2(Disulfide bridge: Cys20-Cys26) |
| P2001487 | Human Growth Hormone (1- 43) | Phe-Pro-Thr-Ile-Pro-Leu-Ser- Arg-Leu-Phe-Asp-Asn-Ala-Met- Leu-Arg-Ala-His-Arg-Leu-His- Gln-Leu-Ala-Phe-Asp-Thr-Tyr- Gln-Glu-Phe-Glu-Glu-Ala-Tyr-Ile- Pro-Lys-Glu-Gln-Lys-Tyr-Ser |
| P2001495 | Hypercalcemia Malignancy Factor (1-34), amide, human | Ala-Val-Ser-Glu-His-Gln-Leu- Leu-His-Asp-Lys-Gly-Lys-Ser-Ile- Gln-Asp-Leu-Arg-Arg-Arg-Phe- Phe-Leu-His-His-Leu-Ile-Ala- Glu-Ile-His-Thr-Ala-NH2 |
| P2001496 | Hypercalcemia Malignancy Factor (1-34), human | Ala-Val-Ser-Glu-His-Gln-Leu- Leu-His-Asp-Lys-Gly-Lys-Ser- Ile-Gln-Asp-Leu-Arg-Arg-Arg- Phe-Phe-Leu-His-His-Leu-Ile- Ala-Glu-Ile-His-Thr-Ala |
| P2001497 | Hypercalcemia Malignancy Factor (1-40) | Ala-Val-Ser-Glu-His-Gln-Leu- Leu-His-Asp-Lys-Gly-Lys-Ser-Ile- Gln-Asp-Leu-Arg-Arg-Arg-Phe- Phe-Leu-His-His-Leu-Ile-Ala- Glu-Ile-His-Thr-Ala-Glu-Ile-Arg- Ala-Thr-Ser |
| P2001498 | Hypercalcemia Malignancy Factor (7-34), amide, human | Leu-Leu-His-Asp-Lys-Gly-Lys- Ser-Ile-Gln-Asp-Leu-Arg-Arg- Arg-Phe-Phe-Leu-His-His-Leu- Ile-Ala-Glu-Ile-His-Thr-Ala-NH2 |
| P2001502 | I-309 (human) | Lys-Ser-Met-Gln-Val-Pro-Phe- Ser-Arg-Cys-Cys-Phe-Ser-Phe- Ala-Glu-Gln-Glu-Ile-Pro-Leu-Arg- Ala-Ile-Leu-Cys-Tyr-Arg-Asn- Thr-Ser-Ser-Ile-Cys-Ser-Asn- Glu-Gly-Leu-Ile-Phe-Lys-Leu- Lys-Arg-Gly-Lys-Glu-Ala-Cys- Ala-Leu-Asp-Thr-Val-Gly-Trp- Val-Gln-Arg-His-Arg-Lys-Met- Leu-Arg-His-Cys-Pro-Ser-Lys- Arg-Lys |
| P2001512 | IL-1b (208-240) (human) | Lys-Lys-Lys-Met-Glu-Lys-Arg- Phe-Val-Phe-Asn-Lys-Ile-Glu-Ile- Asn-Asn-Lys-Leu-Glu-Phe-Glu- Ser-Ala-Gln-Phe-Pro-Asn-Trp- Tyr-Ile-Ser-Thr |
| P2001513 | IL-6 (88-121) (human) | Ile-Ile-Thr-Gly-Leu-Leu-Glu-Phe- Glu-Val-Tyr-Leu-Glu-Tyr-Leu- Gln-Asn-Arg-Phe-Glu-Ser-Ser- Glu-Glu-Gln-Ala-Arg-Ala-Val- Gln-Met-Ser-Thr-Lys |
| P2001539 | Intermedin (human) | Thr-Gln-Ala-Gln-Leu-Leu-Arg- Val-Gly-Cys-Val-Leu-Gly-Thr- Cys-Gln-Val-Gln-Asn-Leu-Ser- His-Arg-Leu-Trp-Gln-Leu-Met- Gly-Pro-Ala-Gly-Arg-Gln-Asp- Ser-Ala-Pro-Val-Asp-Pro-Ser- Ser-Pro-His-Ser-Tyr-NH2 |
| P2001540 | Intermedin (rat) | Pro-His-Ala-Gln-Leu-Leu-Arg- Val-Gly-Cys-Val-Leu-Gly-Thr- Cys-Gln-Val-Gln-Asn-Leu-Ser- His-Arg-Leu-Trp-Gln-Leu-Val- Arg-Pro-Ser-Gly-Arg-Arg-Asp- Ser-Ala-Pro-Val-Asp-Pro-Ser- Ser-Pro-His-Ser-Tyr-NH2 |
| P2001541 | Intermedin-53 (human) | His-Ser-Gly-Pro-Arg-Arg-Thr- Gln-Ala-Gln-Leu-Leu-Arg-Val- Gly-Cys-Val-Leu-Gly-Thr-Cys- Gln-Val-Gln-Asn-Leu-Ser-His- Arg-Leu-Trp-Gln-Leu-Met-Gly- Pro-Ala-Gly-Arg-Gln-Asp-Ser- Ala-Pro-Val-Asp-Pro-Ser-Ser- Pro-His-Ser-Tyr-NH2 |
| P2001552 | KGF Receptor Peptide | His-Ser-Gly-Ile-Asn-Ser-Ser- Asn-Ala-Glu-Val-Leu-Ala-Leu- Phe-Asn-Val-Thr-Glu-Met-Asp- Ala-Gly-Glu-Tyr |
| P2001569 | LEAP-2 (38 - 77) (Human) | Met-Thr-Pro-Phe-Trp-Arg-Gly- Val-Ser-Leu-Arg-Pro-Ile-Gly-Ala- Ser-Cys-Arg-Asp-Asp-Ser-Glu- Cys-Ile-Thr-Arg-Leu-Cys-Arg- Lys-Arg-Arg-Cys-Ser-Leu-Ser- Val-Ala-Gln-Glu |
| P2001585 | LL - 37 pentamide | Leu-Leu-Gly-Asn-Phe-Phe-Arg- Lys-Ser-Lys-Gln-Lys-Ile-Gly-Lys- Gln-Phe-Lys-Arg-Ile-Val-Gln-Arg- Ile-Lys-Asn-Phe-Phe-Arg-Asn- Leu-Val-Pro-Arg-Thr-Gln-Ser |
| P2001586 | LL - 37, Antimicrobial Peptide, human | Leu-Leu-Gly-Asp-Phe-Phe-Arg- Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys- Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg- Ile-Lys-Asp-Phe-Leu-Arg-Asn- Leu-Val-Pro-Arg-Thr-Glu-Ser |
| P2001587 | LL - 37, reverse sequence | Ser-Glu-Thr-Arg-Pro-Val-Leu- Asn-Arg-Leu-Phe-Asp-Lys-Ile- Arg-Gln-Val-Ile-Arg-Lys-Phe-Glu- Lys-Gly-Ile-Lys-Glu-Lys-Ser-Lys- Arg-Phe-Phe-Asp-Gly-Leu-Leu |
| P2001605 | Lytic Peptide, SB – 37 | Met-Pro-Lys-Trp-Lys-Val-Phe-Lys-Lys-Ile-Glu-Lys-Val-Gly-Arg-Asn-Ile-Arg-Asn-Gly-Ile-Val-Lys-Ala-Gly-Pro-Ala-Ile-Ala-Val-Leu-Gly-Glu-Ala-Lys-Ala-Leu-Gly |
| P2001606 | Lytic Peptide, Shiva – 1 | Met-Pro-Arg-Leu-Phe-Arg-Arg-Ile-Asp-Arg-Val-Gly-Lys-Gln-Gly-Ile-Leu-Arg-Ala-Gly-Pro-Ala-Ile-Ala-Leu-Val-Gly-Asp-Ala-Arg-Ala-Val-Gly |
| P2001617 | MARCKS Substrate (151-175) | Lys-Lys-Lys-Lys-Lys-Arg-Phe-pSer-Phe-Lys-Lys-pSer-Phe-Lys-Leu-Ser-Gly-Phe-pSer-Phe-Lys-Lys-Asn-Lys-Lys |
| P2001633 | mCRAMP, mouse | Gly-Leu-Leu-Arg-Lys-Gly-Gly-Glu-Lys-Ile-Gly-Glu-Lys-Leu-Lys-Lys-Ile-Gly-Gln-Lys-Ile-Lys-Asn-Phe-Phe-Gln-Lys-Leu-Val-Pro-Gln-Pro-Glu-Gln |
| P2001674 | Nesfatin-1 (human) | Val-Pro-Ile-Asp-Ile-Asp-Lys-Thr-Lys-Val-Gln-Asn-Ile-His-Pro-Val-Glu-Ser-Ala-Lys-Ile-Glu-Pro-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-Asp-Glu-Tyr-Leu-Lys-Gln-Val-Ile-Asp-Val-Leu-Glu-Thr-Asp-Lys-His-Phe-Arg-Glu-Lys-Leu-Gln-Lys-Ala-Asp-Ile-Glu-Glu-Ile-Lys-Ser-Gly-Arg-Leu-Ser-Lys-Glu-Leu-Asp-Leu-Val-Ser-His-His-Val-Arg-Thr-Lys-Leu-Asp-Glu-Leu |
| P2001675 | Nesfatin-1 (mouse) | Val-Pro-Ile-Asp-Val-Asp-Lys-Thr-Lys-Val-His-Asn-Thr-Glu-Pro-Val-Glu-Asn-Ala-Arg-Ile-Glu-Pro-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-Asp-Glu-Tyr-Leu-Lys-Gln-Val-Ile-Glu-Val-Leu-Glu-Thr-Asp-Pro-His-Phe-Arg-Glu-Lys-Leu-Gln-Lys-Ala-Asp-Ile-Glu-Glu-Ile-Arg-Ser-Gly-Arg-Leu-Ser-Gln-Glu-Leu-Asp-Leu-Val-Ser-His-Lys-Val-Arg-Thr-Arg-Leu-Asp-Glu-Leu |
| P2001676 | Nesfatin-1 (rat) | Val-Pro-Ile-Asp-Val-Asp-Lys-Thr-Lys-Val-His-Asn-Val-Glu-Pro-Val-Glu-Ser-Ala-Arg-Ile-Glu-Pro-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-Asp-Glu-Tyr-Leu-Lys-Gln-Val-Ile-Glu-Val-Leu-Glu-Thr-Asp-Pro-His-Phe-Arg-Glu-Lys-Leu-Gln-Lys-Ala-Asp-Ile-Glu-Glu-Ile-Arg-Ser-Gly-Arg-Leu-Ser-Gln-Glu-Leu-Asp-Leu-Val-Ser-His-Lys-Val-Arg-Thr-Arg-Leu-Asp-Glu-Leu |
| P2001685 | Neuromedin S (human) | Ile-Leu-Gln-Arg-Gly-Ser-Gly-Thr-Ala-Ala-Val-Asp-Phe-Thr-Lys-Lys-Asp-His-Thr-Ala-Thr-Trp-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 |
| P2001686 | Neuromedin S (rat) | Leu-Pro-Arg-Leu-Leu-His-Thr-Asp-Ser-Arg-Met-Ala-Thr-Ile-Asp-Phe-Pro-Lys-Lys-Asp-Pro-Thr-Thr-Ser-Leu-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 |
- 公司简介
-
来宝会员
总公司广州华拓生物科技有限公司于2005年1月在广州天河高新技术工业园诞生，我们将以弃而不舍、勇于开拓、自主创新、敢为人先的智慧和勇气，在生命科学的道路上，不断进取，…... 了解更多>>
